PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo in 2005 and is headquartered in Princeton, NJ.
Cleveland Clinic Florida, Weston, Florida, United States
University of Kentucky Chandler Medical Center - Markey Cancer Center, Lexington, Kentucky, United States
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States
Suffolk Obstetrics & Gynecology, Port Jefferson, New York, United States
Montefiore Medical Center, Bronx, New York, United States